Antimetastatic Role of Smad4 Signaling in Colorectal Cancer
Authors:
Open Access
- 1 March 2010
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 138 (3) , 969-980.e3
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Smad7 induces hepatic metastasis in colorectal cancerBritish Journal of Cancer, 2008
- TGFβ in CancerCell, 2008
- Nuclear localization and intensity of staining of nm23 protein is useful marker for breast cancer progressionCancer Cell International, 2008
- LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasisMolecular Cancer Therapeutics, 2008
- Inhibition of Growth and Metastasis of Mouse Mammary Carcinoma by Selective Inhibitor of Transforming Growth Factor-β Type I Receptor KinaseIn vivoClinical Cancer Research, 2006
- Inhibition of Pulmonary and Skeletal Metastasis by a Transforming Growth Factor-β Type I Receptor Kinase InhibitorCancer Research, 2006
- Metastasis suppressor genes: From gene identification to protein function and regulationCancer Biology & Therapy, 2005
- Smad-dependent and Smad-independent pathways in TGF-β family signallingNature, 2003
- nm23 protein expression in colorectal carcinoma metastasis in regional lymph nodes and the liverEuropean Journal of Surgical Oncology, 2001
- Smad4/DPC4 Silencing and Hyperactive Ras Jointly Disrupt Transforming Growth Factor-β Antiproliferative Responses in Colon Cancer CellsJournal of Biological Chemistry, 1999